82 related articles for article (PubMed ID: 16155844)
21. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O
Pol J Pathol; 2005; 56(3):121-6. PubMed ID: 16334979
[TBL] [Abstract][Full Text] [Related]
22. BX471: a CCR1 antagonist with anti-inflammatory activity in man.
Horuk R
Mini Rev Med Chem; 2005 Sep; 5(9):791-804. PubMed ID: 16178722
[TBL] [Abstract][Full Text] [Related]
23. Regulation of chemokine activity by posttranslational modification.
Mortier A; Van Damme J; Proost P
Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
[TBL] [Abstract][Full Text] [Related]
24. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
[TBL] [Abstract][Full Text] [Related]
25. Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions.
Strong AE; Thierry AC; Cousin P; Moulon C; Demotz S
Eur Cytokine Netw; 2006 Mar; 17(1):49-59. PubMed ID: 16613763
[TBL] [Abstract][Full Text] [Related]
26. [Chemokine directed homing of transplanted adult stem cells in wound healing and tissue regeneration].
Huss R; von Lüttichau I; Lechner S; Notohamiprodjo M; Seliger C; Nelson P
Verh Dtsch Ges Pathol; 2004; 88():170-3. PubMed ID: 16892549
[TBL] [Abstract][Full Text] [Related]
27. The role of chemokines in rheumatoid arthritis and osteoarthritis.
Vergunst CE; van de Sande MG; Lebre MC; Tak PP
Scand J Rheumatol; 2005; 34(6):415-25. PubMed ID: 16393761
[TBL] [Abstract][Full Text] [Related]
28. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
[TBL] [Abstract][Full Text] [Related]
29. Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation.
Gupta S; Fuchs B; Schulz-Maronde S; Heitland A; Escher SE; Mack M; Tillmann HC; Braun A; Forssmann WG; Elsner J; Forssmann U
J Leukoc Biol; 2008 Mar; 83(3):765-73. PubMed ID: 18063698
[TBL] [Abstract][Full Text] [Related]
30. Keeping out the bad guys: gateway to cellular target therapy.
Kitamura T; Taketo MM
Cancer Res; 2007 Nov; 67(21):10099-102. PubMed ID: 17974948
[TBL] [Abstract][Full Text] [Related]
31. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology.
Toda M; Nakamura T; Ohbayashi M; Ikeda Y; Dawson M; Richardson RM; Alban A; Leed B; Miyazaki D; Ono SJ
Novartis Found Symp; 2005; 271():131-40; discussion 140-51. PubMed ID: 16605132
[TBL] [Abstract][Full Text] [Related]
32. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
Chen X; Oppenheim JJ; Howard OM
Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
[TBL] [Abstract][Full Text] [Related]
33. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
Richter R; Casarosa P; Ständker L; Münch J; Springael JY; Nijmeijer S; Forssmann WG; Vischer HF; Vakili J; Detheux M; Parmentier M; Leurs R; Smit MJ
J Immunol; 2009 Jul; 183(2):1229-37. PubMed ID: 19553544
[TBL] [Abstract][Full Text] [Related]
34. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
Ali S; O'Boyle G; Mellor P; Kirby JA
Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
36. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
[TBL] [Abstract][Full Text] [Related]
37. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
Suresh P; Wanchu A
J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325
[TBL] [Abstract][Full Text] [Related]
38. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
39. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis.
Pokkali S; Das SD
Hum Immunol; 2009 Feb; 70(2):110-5. PubMed ID: 19100801
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process.
Silva AA; Roffê E; Santiago H; Marino AP; Kroll-Palhares K; Teixeira MM; Gazzinelli RT; Lannes-Vieira J
J Neuroimmunol; 2007 Mar; 184(1-2):156-63. PubMed ID: 17275101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
